Numbness, Fatigue, Vision Changes. Your Genes May Explain Why.

HLA-DQ2 is a protein on the surface of your immune cells that displays fragments of proteins to your T-cells, essentially saying, ‘Is this a threat?’ Your immune system learns what to attack based on what HLA-DQ2 shows it. If you have HLA-DQ2, your immune cells are shown myelin fragments in a way that makes them look dangerous, even though they’re part of your own nervous system.

Roughly 25-30% of people with European ancestry carry HLA-DQ2. In people with MS, this number is much higher, roughly 90-95%. If you have HLA-DQ2, your immune system has a genetic predisposition to view your own myelin as foreign and attack it. This is the foundational risk factor for MS. Without HLA-DQ2, MS is rare. With it, your risk depends on other genes and environmental triggers.

You might notice that your immune system reacts strongly to viral infections, or that you develop multiple food sensitivities. Your body’s immune surveillance is heightened. You might get frequent sinus infections or take longer to recover from colds. Over time, if you’re exposed to certain viruses (especially Epstein-Barr) and have low vitamin D, that heightened surveillance turns inward and your immune system begins attacking myelin.

Interleukin-6 is a signaling molecule that tells your immune system to increase inflammation. In small amounts, it’s necessary for immune response. But if your IL6 gene has the C allele variant, you produce more IL-6 than baseline, especially in response to stress, infection, or injury. This extra IL-6 amplifies inflammatory signals throughout your body and specifically in your brain and spinal cord.

Approximately 40% of people carry the C allele. In people with MS, the percentage is higher, around 50-60%. IL6 variants mean your immune system has a built-in amplifier for inflammatory signaling. When something triggers immune activation, IL-6 turns up the volume. This is especially dangerous in the brain and spinal cord, where neuroinflammation damages myelin faster.

You might experience brain fog or difficulty concentrating, especially after infections or stressful periods. Your recovery from illness might be slower, or inflammation in your joints or muscles might be noticeable. You might notice that you’re more sensitive to heat (neuroinflammation worsens with higher body temperature), or that your symptoms flare after intense stress.

The VDR gene codes for the vitamin D receptor, a protein that allows your cells to respond to vitamin D. When vitamin D binds to VDR, it triggers a cascade of immune-suppressing signals, telling T-cells to calm down and preventing autoimmune overactivity. If you have VDR variants, your cells don’t respond to vitamin D as efficiently. You need more vitamin D to achieve the same immune-suppressing effect, and even then, the effect may be weaker.

Roughly 40-50% of the population carries VDR variants. In MS populations, carriers have higher disease activity. VDR variants mean you have a genetically reduced capacity to use vitamin D to suppress autoimmune activation. This is why low vitamin D is such a strong risk factor for MS, and why some people with adequate vitamin D levels still develop MS. If you have VDR variants, ‘adequate’ isn’t enough; you need ‘optimal’.

You might find that you get sick more frequently, that your immune system overreacts to minor infections, or that you have seasonal patterns to your symptoms (more flares in winter when vitamin D is lower). You might have a history of other autoimmune conditions, or family history of autoimmunity. Your baseline inflammation might be subtly elevated even when you feel well.

Tumor necrosis factor-alpha (TNF) is a cytokine that orchestrates inflammatory signals throughout your body. In small amounts, it’s part of normal immune response. But the TNF -308G>A variant increases TNF-alpha production, creating a baseline of higher systemic inflammation. This elevated inflammation circulates everywhere, including across the blood-brain barrier where it can trigger neuroinflammation and myelin attack.

Roughly 30% of people carry the A allele. In MS patients, especially those with early-onset disease, the percentage is higher. TNF variants mean your immune system produces more inflammatory signals at baseline, creating a permissive environment for autoimmune attack. Even on quiet days when you feel fine, your cytokine levels are higher than baseline.

You might notice that you have low-grade fatigue that doesn’t match your activity level, or that you feel generally achey. Joint pain or muscle soreness might be present without clear cause. You might run a slight low-grade fever occasionally, or have persistent low-level lymph node swelling. Your body feels like it’s constantly mounting a response to something, even when nothing obvious is wrong.

CTLA4 is a checkpoint protein on T-cells that acts as a brake, preventing immune cells from staying activated too long. When your immune system detects a threat, T-cells activate, attack the threat, then CTLA4 tells them to stand down. If you have the CTLA4 +49A>G variant, that brake doesn’t work as efficiently. Your T-cells stay activated longer, and they attack longer before receiving the signal to stop.

Approximately 45% of the population carries the G allele. In MS patients, especially those with active disease, the percentage is elevated. CTLA4 variants mean your T-cell ‘off switch’ is less effective, allowing autoimmune attack to continue unchecked. You have the genetic equivalent of a stuck accelerator with weak brakes.

You might notice that you have cycles of symptom flares where each flare is worse than the last, or lasts longer. Your immune system might overreact to minor triggers (a small infection becomes a major illness). You might have a history of other autoimmune conditions, or that multiple family members have autoimmune disease. Once your symptoms start, they tend to persist rather than resolve quickly.

MTHFR codes for an enzyme that converts B vitamins into their active, methylated forms. These methylated B vitamins (methylfolate and methylcobalamin) are required for DNA methylation, which controls gene expression, including genes that suppress inflammation and regulate immune tolerance. If you have MTHFR C677T or A1298C variants, your enzyme works at 40-70% efficiency. Your cells can’t convert B vitamins into usable forms, so you’re functionally depleted in methylation capacity even if your bloodwork looks normal.

Roughly 30-40% carry the C677T variant. In MS and other autoimmune conditions, MTHFR variants are overrepresented. MTHFR variants mean you have a genetic bottleneck in methylation, which impairs both DNA repair and immune regulation. Your immune system can’t properly suppress itself, and your nervous system can’t repair damage from inflammation.

You might experience cognitive symptoms (brain fog, word-finding difficulty), mood changes (anxiety or depression), or heightened stress sensitivity. You might have poor tolerance for stress or environmental toxins. Your symptoms might worsen after taking regular folic acid supplements (which require MTHFR to activate) or after exposure to certain chemicals. You might have slow recovery from infections or injuries.